Outcomes of gout in patients with cirrhosis: A national inpatient sample-based study

Table 4 Primary outcomes in gout among hospitalized patients with and without cirrhosis

	Patients without cirrhosis		Patients with cirrhosis		OR	95%CI	P value	AOR	ACI	Adjusted P value
	Percentage	n	Percentage	n
Mortality	2.03	30286	5.49	2029	2.804	2.678-2.937	< 0.050	3.092	2.939-3.252	< 0.05
Gout flare	2.77	41282	2.89	1066	1.044	0.982-1.110	0. 171	0.816	0.765-0.871	< 0.05
Tophi	0.75	11202	0.97	358	1.293	1.164-1.438	< 0.050	1.025	0.914-1.149	0.677
Uric acid nephrolithiasis	0.02	374	0.02	9	0.972	0.502-1.882	0.932	1.037	0.530-2.030	0.915
Nephropathy	0.02	283	0.01	5	0.713	0.295-1.727	0.452	0.548	0.223-1.346	0.19
Arthrocentesis	2.45	36611	2.21	818	0.900	0.839-0.965	< 0.050	0.741	0.686-0.800	< 0.05
Joint injection	0.72	10673	0.52	192	0.725	0.628-0.837	< 0.050	0.713	0.610-0.833	< 0.050
Septic Arthritis	0.31	4637	0.31	114	0.993	0.824-1.196	0.939	0.997	0.821-1.211	0.977

95%CI: 95% Confidence interval; ACI: Adjusted confidence interval; AOR: Adjusted odds ratio; OR: Odds ratio.